Screening of Renal Cancer
- Conditions
- Malignant neoplasm of unspecifiedkidney, except renal pelvis,
- Registration Number
- CTRI/2020/08/027398
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
The spectroscopic techniques are emerging as an effective tool for detection of cancers in an effective way.This technique has a potential to be used as an alternative of biopsy which is called as optical biopsy.This single center observational study mainly aims the development of a compact device which is capable of acting like an optical biopsy device.Along with that the HPLC-LIF system will be giving the protein profiles of body fluids which in
turn gives the early signatures of renal cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 105
All above 18 years of age and having malignant or benign type of kidney cancer (like clear cell renal cell carcinoma, urothelial carcinoma, chromophobe renal cell carcinoma, oncocytoma,angiomyolipoma and cystic renal cell carcinoma) are included.
All male and female below age 18 are excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The fluorescence spectroscopy can be very useful to explore the mechanism involved during the progression of renal cancer. Along with multivariate data analysis the fluorescence spectra can give useful information for the objective diagnosis of tissue samples. The Raman spectrum and the HPLC-LIF protein profile can give complementary information of the tissue along with the LIF based diagnosis. 3 years
- Secondary Outcome Measures
Name Time Method It can be extended to different type of cancer such as breast cancer. 3 years
Trial Locations
- Locations (1)
Kasturba Medical College, MAHE, Manipal
🇮🇳Udupi, KARNATAKA, India
Kasturba Medical College, MAHE, Manipal🇮🇳Udupi, KARNATAKA, IndiaDr Santhosh ChidangilPrincipal investigator9880092297santhosh.cls@manipal.edu